Previous 10 | Next 10 |
AngioDynamics shares rise ([[ANGO]] +2.1%) after the company posted fourth-quarter revenue that beat Wall Street estimates, helped by the strength in its endovascular therapies business, and provided a financial forecast for the year.Net sales during the quarter rose 32% to $76.84M, beat...
The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: AngioDynamics, Inc. 2021 Q4 - Results - Earnings Call Presentation
Fiscal 2021 Fourth Quarter Highlights Net sales of $76.8 million increased 31.7% compared to the prior-year quarter Gross margin of 55.1% increased 330 basis points year over year GAAP loss per share of $0.51, inclusive of a $14.0 million write-off of OAR...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will host its Investor & Technology Day on Tuesday, July 13, from 9:30 a.m. to approximate...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the fourth quarter and fiscal year 2021 before the market op...
AngioDynamics (ANGO) has received 510(k) clearance from the FDA for the AlphaVac Mechanical Thrombectomy System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the non-surgical removal of thrombi or emboli from the vasculature. AngioDynamics continues to anticipat...
Company to Hold Fiscal Fourth Quarter and Fiscal Year 2021 Earnings Conference Call and Virtual Investor and Technology Day on July 13, 2021 AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripher...
The following slide deck was published by AngioDynamics, Inc. in conjunction with this event. For further details see: AngioDynamics (ANGO) Presents At UBS Global Healthcare Virtual Conference - Slideshow
Shares of AngioDynamics Inc. (NASDAQ:ANGO) traded at a new 52-week high today of $24.83. So far today approximately 117,000 shares have been exchanged, as compared to an average 30-day volume of 323,000 shares. In the past 52 weeks, shares of AngioDynamics Inc. have traded between a low ...
AngioDynamics had a basically inline fiscal third quarter on strength in AngioVac and Auryon, but the shares have rerated much higher on growing enthusiasm for the company's growth strategy. AngioVac continues to gain shares in relatively small VTE sub-markets, but management's produc...
News, Short Squeeze, Breakout and More Instantly...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that its management is schedule...
Equity Bancshares Inc. Class A (EQBK) is expected to report $0.92 for Q2 2024 Bank of America Corporation (BAC) is expected to report $0.79 for Q2 2024 Aehr Test Systems (AEHR) is expected to report $0.09 for Q4 2024 America Movil S.A.B. de C.V.n Depositary Shares (each representing t...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the fourt...